Covid19 Europe 

Russia approves ‘game-changer’ antiviral drug to treat coronavirus

Russia has approved a ‘game-changer’ antiviral drug to treat the coronavirus and is ready to start giving it to infected patients next week. The Health Ministry in Russia has approved Avifavir, following the promising results of the first phase of clinical trials of the medication. Covid-19 patients given the drug recovered in half the time compared to those who took a placebo and that it cures 90 per cent of patients in 10 days, health chiefs claimed. Russian officials modified a version of the generic drug favipiravir, a drug designed…

Read More
Africa Asia Australasia Covid19 Europe North America South America 

Was That Cold I Had in November or December Coronavirus?

It is a comforting thought at a time of mass death from a historic and unpredictable pandemic: What if I had it already maybe even that time I felt sick a few months ago? After all, while antibody testing is only now being rolled out in any significant numbers and its reliability remains in doubt the hope is that having recovered from the illness might offer some measure of immunity to reinfection. And the documented prevalence of so-called silentor asymptomaticspreaders suggests many Americans have unknowingly been infected. But public health…

Read More
Covid19 Europe 

“No Evidence” People With Covid-19 Antibodies Are Immune From Second Infection, Says WHO

The World Health Organization (WHO) has warned there is “no evidence” that people with antibodies to Covid-19 have necessarily acquired immunity to the disease and are protected against a second infection. Some countries, such as Germany, are looking to roll out “immunity passports” that would allow people to be free from some lockdown measures if they can prove they have recovered from Covid-19. However, the WHO has warned governments against this idea as the effectiveness of antibody testing has not been proven.  “As of 24 April 2020, no study has evaluated…

Read More
Asia Covid19 

New COVID-19 test developed in Singapore detects past infection within an hour

A new COVID-19 test that can rapidly assess if a person has been previously infected with the coronavirus is now available to hospitals in Singapore. Launched on Friday (May 15), the cPass serology test detects antibodies – formed by the body to fight off infections – in the blood or serum of patients. It is not used to check for active infection. Its main purpose rather, is for contact tracing, detecting asymptomatic cases and assessing herd immunity. Such serological tests have been used in Singapore for contact tracing. What is different about the new…

Read More